AstraZeneca Plc reported better-than-expected profit and sales in the fourth quarter and forecast further gains as the UK drugmaker’s blockbuster cancer drugs offset weakened China sales.

Quantum computing is shaping up to be the next big investing revolution, and for a very good reason. With the power to solve ...

Google's balance sheet is impressive, with negative long-term debt, $110 billion in cash, and a forward dividend yield of ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...

Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Earnings per share rose 24% to $3.41, compared to Wall Street's consensus estimate of $2.96, according to FactSet. Revenue for the quarter reached $11.67 billion, well above expectations of $10.91 ...

The Bank of England is expected to enact a 25 basis point rate cut on Thursday, but policymakers face the unenviable balancing act of weighing up a stalling economy with inflation pressure. The ...

Investors in Europe will wake up to an action-packed Thursday spanning a rate decision from the Bank of England (BoE) and a ...

Indian retailer Trent reported third-quarter profit above estimates on Thursday as urban shoppers splurged on clothes and beauty products during the festive season. The firm, which owns the popular ...

Contributing to the German beauty company’s strong growth trajectory were its U.S. business and social media backing.